Blood coagulation multi-item joint detection test strip and adaptive detection device
Through lyophilized bead technology and sealing membrane packaging, the problem of difficulty in maintaining enzyme activity in the coagulation reagent strip is solved, achieving more accurate measurement and convenient transportation.
Patent Information
- Application Number
- CN202411235719.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-04
- Publication Date
- 2024-11-26
AI Technical Summary
In the existing coagulation reagent strips, the activity of enzyme/protein is difficult to maintain, resulting in large errors in the measurement results.
Using lyophilized bead technology, lyophilized beads with loose mesh structures are formed by liquid nitrogen freezing and vacuum drying, and separated from functional reagents to be placed in a transparent container. They are encapsulated with sealing membrane to ensure enzyme activity and convenient transportation. .
The storage capacity and enzyme activity of lyophilized beads are significantly enhanced, measurement errors are reduced, and transportation convenience is improved.
Smart Images

Figure CN119023976A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of coagulation reagent strips, and in particular to a coagulation multiple combined detection test strip and a detection device adapted thereto. Background Art
[0002] In the field of medical testing and research, during the process of blood testing, after obtaining a blood sample from a subject (such as earlobe or fingertip blood, venous blood), in order to prevent the blood sample from coagulating during storage or transfer, the blood is usually anticoagulated, such as by artificially adding anticoagulants such as sodium citrate.
[0003] Blood coagulation screening tests are required in clinical testing and routine screening, including prothrombin time (PT, Prothrombin Time), activated partial thromboplastin time (APTT, Activated Partial Thromboplastin Time), activated clotting time (ACT, Activated Clotting Time), fibrinogen content (FIB, fibrinogen content) and thrombin time (TT, Thrombin Time). Various detection instruments are now provided in this field, and clinical laboratories, health practitioners, etc. test the types of blood coagulation characteristics under specific conditions; in the prior art, such as the utility model patent with application number 201711147040.9, a detection reagent is disclosed, in which the detection reagent strip can be used for chemiluminescence immunoassay and solid-phase enzyme immunoassay, and the reagents required for the detection are all loaded on the detection reagent strip, realizing the integration of the reagent strip, simplifying the detection steps, avoiding pollution, and being able to achieve effective qualitative or quantitative detection and analysis of multiple indicator substances; however, it is found in actual use that the types of reagents used in the reagent strip are all in liquid form. During the detection process, the activity of the enzyme / protein is difficult to maintain, which will cause a large error in the measurement result. Therefore, a more reasonable solution is urgently needed to solve the above-mentioned technical problems. Summary of the invention
[0004] The present invention provides a solution to the technical problem that in the prior art test strips, since the reagents used are all in liquid form, the activity of the enzyme / protein is difficult to maintain during the detection process, which will cause a large error in the measurement result.
[0005] To achieve the above-mentioned objectives, the present invention provides a coagulation multi-item combined detection test strip, comprising a main body, on which a first receiving groove is arranged, and the profile forming the first receiving groove is made of a transparent material, the number of the first receiving grooves is equal to the detection items of the test strip, and each of the first receiving grooves is correspondingly provided with a freeze-dried bead adapted to the detection item; the main body also includes a second receiving groove, and the second receiving groove is provided with a plurality of second receiving grooves, and each of the second receiving grooves contains a functional reagent that reacts with the freeze-dried beads; the surface of the main body is also provided with a sealing film for sealing the first receiving groove and the second receiving groove.
[0006] As an improved solution of the present application, the freeze-dried beads are obtained by the following preparation method: Configuration: Obtain corresponding components according to the type of the test item and compound them to form liquid reagents; Making drop beads: forming droplets of expected volume by the liquid reagent, and rapidly freezing the droplets by liquid nitrogen to obtain initial frozen beads; Freeze-drying: The freeze-dried beads are collected and freeze-dried to form the freeze-dried beads with a loose network structure.
[0007] As an improved solution of the present application, in the freeze-drying step, the parameters of the freeze-drying process are: Pre-freezing stage: temperature: -45℃-40℃; duration: 3-6h; Sublimation stage: temperature: -30℃-35℃; duration: 6-11h; vacuum degree <10pa; Analytical drying: temperature: 5℃-25℃; duration: 4-10h; vacuum degree <10pa.
[0008] As an improved solution of the present application, in the freeze-drying step, the sublimation stage is divided into: The first sublimation stage: temperature: -30℃-35℃; duration: 4-7h; vacuum degree <10pa; Second sublimation stage: temperature: -20℃-25℃; duration: 2-4h; vacuum degree <10pa.
[0009] As an improved solution of the present application, in the freeze-drying step, the analytical drying is divided into: The first analysis stage: temperature: 5℃-10℃; duration: 2-4h; vacuum degree <10pa; Second analysis stage: temperature: 20℃-25℃; duration: 2-6h; vacuum degree <10pa.
[0010] As an improved solution of the present application, the types of detection items are four types: APTT, PT, TT and FIB.
[0011] As an improved solution of the present application, the freeze-dried beads used for detecting the APTT project are silica freeze-dried beads, which are compounded with buffer, silica, cephalin, stabilizer, preservative and plasticizer; The freeze-dried beads used for detecting the PT project are tissue factor freeze-dried reagents, and the tissue factor freeze-dried beads are compounded with a buffer, recombinant tissue factor rhTF, a stabilizer, a preservative, and a plasticizer; The freeze-dried beads used for detecting the TT project are bovine thrombin freeze-dried reagents, which are compounded with buffer, silica, cephalin, stabilizer, preservative and plasticizer; The freeze-dried beads used for detecting the FIB project are standard bovine thrombin freeze-dried reagents, which are compounded with a buffer, bovine thrombin, a stabilizer, a preservative and a plasticizer.
[0012] As an improved solution of the present application, the functional reagents are a complex solution, an APTT reagent R1 and a sample diluent.
[0013] As an improved solution of the present application, the inner wall width of the first accommodating groove gradually increases from the groove bottom to the groove opening.
[0014] The present application also provides a detection device for detecting any of the above-mentioned coagulation multiple combined detection test strips.
[0015] The beneficial effects of the present invention are as follows: compared with the prior art, the present invention provides a coagulation multi-item combined detection test strip and a detection device adapted thereto, the combined detection test strip comprising a main body, a first receiving groove arranged on the main body, and a profile forming the first receiving groove is made of a transparent material, the number of the first receiving grooves is equal to the detection items of the test strip, and freeze-dried beads adapted to the detection items are placed in each first receiving groove; the main body also comprises a second receiving groove arranged thereon, a plurality of second receiving grooves are provided, and functional reagents reacting with the freeze-dried beads are respectively contained therein; a sealing film for sealing the first receiving groove and the second receiving groove is further provided on the surface of the main body; the functional reagent and the freeze-dried beads are separated and placed to prevent mutual interference, and the agent that mainly reacts with the blood sample is the freeze-dried beads in solid form, which significantly enhances its storage capacity and can ensure the activity of the enzyme; further, a sealing film for sealing the first receiving groove and the second receiving groove is further provided on the surface of the main body, and the sealing film can be stored and transported at room temperature after being packaged by the sealing film, thereby increasing the convenience of transportation. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 A perspective view of the present invention; Figure 2 It is another perspective view of the present invention; Figure 3 It is a schematic diagram of the detection device of the present invention.
[0017] The main component symbols are described as follows: 1. First containing tank; 2. Second containing tank; 3. Tip tank 3; 4. Sample tank; 5. Detection device; 51. Inlet and outlet assembly; 52. Piercing needle; 53. Injection needle; 54. Light-emitting assembly. DETAILED DESCRIPTION
[0018] In order to more clearly illustrate the present invention, the present invention is further described below in conjunction with the accompanying drawings.
[0019] In the following description, the example details are given to provide a deeper understanding of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all embodiments. It should be understood that the specific embodiments are only used to explain the present invention and are not used to limit the present invention.
[0020] It should be understood that when the terms "include" and / or "comprises" are used in this specification, they indicate the existence of the stated features, integers, steps, operations, elements or components, but do not exclude the existence or addition of one or more other features, integers, steps, operations, elements, components or combinations thereof.
[0021] In the prior art, since the reagents used are all in liquid form, the activity of the enzyme / protein is difficult to maintain during the detection process, which will cause a large error in the measurement result. In order to solve the above technical problems, the present application provides a coagulation multiple combined detection test strip, please refer to the attached Figure 1 To Attachment Figure 3The joint detection test strip includes a main body, on which a first receiving groove 1 is arranged, and the profile forming the first receiving groove 1 is a transparent material, the number of the first receiving grooves 1 is equal to the detection items of the test strip, and each first receiving groove 1 is correspondingly placed with a freeze-dried bead adapted to the detection item; the main body also includes a second receiving groove 2, and the second receiving groove 2 is provided with a plurality of functional reagents that react with the freeze-dried beads; the surface of the main body is also provided with a sealing film for sealing the first receiving groove 1 and the second receiving groove 2; the first receiving groove 1 is used not only to store the freeze-dried beads that mainly react with the blood sample, but also to be used as a detection position, so it is necessary to specially set this part of the profile to be transparent, and during the detection, it is irradiated with light of a specific frequency band to detect the required value accordingly; naturally, in a better implementation scheme, a Tip head hole can be further provided in the main body for placing a pipette head, and a sample slot can also be provided for collecting blood samples, and the sealing film can also seal the Tip head hole and the sample The sample slot is sealed to ensure the cleanliness of the hole wall; in the specific use process, the technician first tears off the sealing film of the sample slot and the Tip slot, and collects the blood sample of the person to be tested in the sample slot, and installs the pipette head on the sample adding needle of the detection device 5. When working, the joint test reagent strip is first placed on the inlet and outlet component 51 of the detection device 5. The inlet and outlet component 51 moves the joint test reagent strip to the detection position based on the driving motor. During the detection, the puncture needle 52 of the detection device 5 punctures the sealing film of the first receiving slot 1, and the blood sample and the functional reagent are added to the first receiving slot 1 through the sample adding needle. The blood sample reacts with the freeze-dried beads and is illuminated by the light-emitting component 54 of the detection device 5. The signal receiver of the detection device 5 collects the light-receiving condition of the blood sample to generate a corresponding light signal, and the computing chip of the detection device 5 analyzes the coagulation degree and time of the blood sample according to the light signal, thereby completing the detection of the blood sample.
[0022] The functional reagents and freeze-dried beads are placed separately to prevent mutual interference, and the reagents that mainly react with the blood sample are freeze-dried beads in solid form, which significantly enhances its storage capacity and can ensure the activity of the enzyme; further, the surface of the main body is also provided with a sealing film for sealing the first containing groove 1 and the second containing groove 2, which can be stored and transported at room temperature after being packaged by the sealing film, thereby increasing the convenience of transportation.
[0023] In a specific embodiment, the freeze-dried beads are obtained by the following preparation method: S1. Configuration: Obtain corresponding components according to the type of test items and compound them to form liquid reagents; S2. Making drop beads: forming a liquid reagent into droplets of expected volume, and rapidly freezing the droplets with liquid nitrogen to obtain initial frozen beads; S3. Freeze-drying: Collect the freeze-dried beads and perform freeze-drying treatment on them. After the freeze-drying treatment is completed, freeze-dried beads with a loose network structure are formed.
[0024] The preparation of freeze-dried beads is achieved through the above steps. In the freeze-drying stage, the substance containing a large amount of water is cooled and frozen into a solid in advance, and then the solid water is directly sublimated under vacuum conditions, while the substance itself remains in the ice shelf when frozen. Therefore, its volume remains unchanged after drying, forming a loose porous network structure. According to the degree of freeze-drying, the longer the freeze-drying time, the looser the freeze-dried beads are, and the higher the dissolution rate when used. Moreover, based on the freeze-drying technology, the activity of the enzyme will not be affected, and the redissolution is rapid after mixing with the functional additives, so a stable packaging environment can be formed to measure the blood sample.
[0025] More specifically, in the S1 configuration step, the types of detection items are APTT, PT, TT and FIB; the freeze-dried beads used to detect the APTT item are silica freeze-dried beads, which are compounded with buffer, silica, phospholipids, stabilizers, preservatives and plasticizers; in terms of components, the buffer is 0.02~1M, the mass of silica accounts for 0.01~1w / v% of the volume of the buffer; the mass of phospholipids accounts for 0.01~1w / v% of the volume of the buffer; the mass of the stabilizer accounts for 0.1~5w / v% of the volume of the buffer; the mass of the preservative accounts for 0.03~1w / v% of the volume of the buffer; the mass of the excipient accounts for 0.01~1w / v% of the volume of the buffer.
[0026] The freeze-dried beads used to detect the PT project are tissue factor freeze-dried reagents. The tissue factor freeze-dried beads are compounded by buffer, recombinant tissue factor rhTF, stabilizer, preservative and plasticizer; among them, in terms of components, the buffer is 0.02~1M; the mass of recombinant tissue factor accounts for 0.1~1w / v% of the volume of the buffer; the mass of the stabilizer accounts for 0.1~5w / v% of the volume of the buffer; the mass of the preservative accounts for 0.03~1w / v% of the volume of the buffer; the mass of the excipient accounts for 0.01~1w / v% of the volume of the buffer.
[0027] The freeze-dried beads used to detect the TT project are bovine thrombin freeze-dried reagents, which are compounded by buffer, silica, cephalin, stabilizer, preservative and plasticizer; among them, in terms of components, buffer 0.02~1M; bovine thrombin 10~60U / mL; the mass of stabilizer accounts for 0.1~5w / v% of the volume of buffer; the mass of preservative accounts for 0.03~1w / v% of the volume of buffer; the mass of excipient accounts for 0.01~1w / v% of the volume of buffer.
[0028] The freeze-dried beads used for testing FIB projects are standard bovine thrombin freeze-dried reagents, which are compounded with buffer, bovine thrombin, stabilizer, preservative and plasticizer; among them, the components are 0.02~1M buffer; 18~30U / mL bovine thrombin; the mass of stabilizer accounts for 0.1~5w / v% of the volume of buffer The mass of preservatives accounts for 0.03~1w / v% of the volume of the buffer solution; the mass of excipients accounts for 0.01~1w / v% of the volume of the buffer solution.
[0029] More specifically, in step S3, the freeze-dried beads obtained by compounding the above components can quickly detect blood samples and can simultaneously detect the above four coagulation items, making the detection more efficient and quick.
[0030] More specifically, in S2, in making drop beads, the prepared liquid reagent is divided into 2-30ul droplets by a micropump, and this volume can be quickly frozen into a frozen bead state by liquid nitrogen; The freeze-dried beads making instrument operates as follows: 1) Turn on the machine to start the bead quantitative system and log in the system; 2) Connect the dripping pipes and needles for each project of the dripping quantitative system; 3) Rinse the dropper and needle; 4) After rinsing, turn on the air compressor, set the dripping parameters, adjust the dripping target volume, and prepare for dripping after setting the parameters; 5) Use a micro pump to drip to obtain the initial frozen beads.
[0031] In a more specific embodiment, in the freeze-drying step S3, the freeze-drying process parameters are: Pre-freezing stage: temperature: -45℃-40℃; duration: 3-6h; Sublimation stage: temperature: -30℃-35℃; duration: 6-11h; vacuum degree <10pa; Analytical drying: temperature: 5℃-25℃; duration: 4-10h; vacuum degree <10pa.
[0032] The initial frozen beads are processed through the above-mentioned pre-freezing stage, sublimation stage or analysis stage, so that a large amount of water molecules are sublimated and emitted, thereby retaining the core reaction substances for use, and making the reaction substances form a loose and porous state, which is convenient for absorption and reaction with functional reagents.
[0033] In a preferred embodiment, in the freeze-drying step, the sublimation stage is divided into: The first sublimation stage: temperature: -30℃-35℃; duration: 4-7h; vacuum degree <10pa; Second sublimation stage: temperature: -20℃-25℃; duration: 2-4h; vacuum degree <10pa.
[0034] In a preferred embodiment, in the freeze-drying step, analytical drying is divided into: The first analysis stage: temperature: 5℃-10℃; duration: 2-4h; vacuum degree <10pa; Second analysis stage: temperature: 20℃-25℃; duration: 2-6h; vacuum degree <10pa.
[0035] The sublimation stage and the analytical drying stage are divided into two stages, and the initial frozen beads are processed in four small stages in total, so that the overall freeze-drying degree is more reasonable and the strength of the loose porous structure of the freeze-dried beads is better.
[0036] In this embodiment, the functional reagents are cleaning solution, resolving solution, APTT reagent R1 and sample diluent; specifically, the sample diluent is composed of imidazole buffer and preservative, wherein the imidazole buffer is 0.05~3M; the mass of the preservative is 0.03~1w / v% of the volume of the imidazole buffer; the resolving solution is composed of buffer and sodium hypochlorite, wherein the buffer is 0.02~1M, and the mass of sodium chloride is 0.03~0.1w / v% of the volume of the solution; the cleaning solution is composed of sodium hypochlorite and surfactant, wherein the volume of sodium hypochlorite is 5~30v / v% of the volume of the solution, and the mass of the surfactant is 0.01~1w / v% of the volume of the solution; The types of components involved are: The reconstitution solution can be HEPES, PBS buffer, Tris buffer corresponding to the buffer used for the reagents, or physiological saline, purified water, or distilled water; Sample diluents include, but are not limited to: imidazole, barbital, sodium chloride, preservatives, etc.; Cleaning fluids include but are not limited to: sodium hypochlorite, stabilizer, etc.; The above stabilizers include but are not limited to: sucrose, fructose, BSA, trehalose, amino acids, etc.; The above preservatives include but are not limited to: PC300, DN, KV100, KV300, Kasong, etc.; The above plasticizers include but are not limited to: mannitol, dextran, PEG8000, PEG6000, etc.; The pH value of the above buffers is 6-9, including but not limited to: Tris buffer, HEPES buffer, PBS buffer, etc.; The above surfactants include but are not limited to: Tween series ~ Tween 20, 80, 60, etc., Triton series, Triton15, 100, 405, etc.
[0037] In the present embodiment, the inner wall width of the first receiving groove 1 gradually increases from the groove bottom to the groove mouth. It is not difficult to understand that during detection, the freeze-dried beads are placed at the bottom of the first receiving groove 1. Since the first receiving groove 1 has a certain taper, the freeze-dried beads can be immersed in a smaller volume of functional additives and blood samples to react, and a larger operating space can be obtained, which can increase the working stability of the puncture needle and the injection needle 53.
[0038] The present application also provides a detection device 5 for detecting any of the above-mentioned coagulation multi-item combined test strips; the detection device 5 includes an input and output group, a puncture needle 52, a sample addition needle, a light-emitting component 54 and a signal collector. The specific coordination can refer to the aforementioned content and will not be elaborated here.
[0039] The advantages of the present invention are: 1. The functional reagents and freeze-dried beads are placed separately to prevent mutual interference, and the reagents that mainly react with the blood sample are freeze-dried beads in solid form, which significantly enhances its storage capacity and can ensure the activity of the enzyme; further, a sealing film for sealing the first containing groove and the second containing groove is provided on the surface of the main body, and after being packaged by the sealing film, it can be stored and transported at room temperature, which increases the convenience of transportation.
[0040] 2. During the freeze-drying stage, the substance containing a large amount of water is cooled and frozen into a solid in advance, and then the solid water is directly sublimated under vacuum conditions, while the substance itself remains in the ice shelf during freezing. Therefore, its volume remains unchanged after drying, forming a loose porous network structure, which will not destroy the activity of proteins / enzymes and will re-dissolve quickly, making measurement more convenient.
[0041] The above disclosures are only several specific embodiments of the present invention, but the present invention is not limited thereto, and any changes that can be conceived by those skilled in the art should fall within the protection scope of the present invention.
Claims
1. A coagulation multiple combined test strip, characterized in that: It includes a main body, on which a first receiving groove is arranged, and the profile forming the first receiving groove is a transparent material, the number of the first receiving grooves is equal to the detection items of the test strip, and each of the first receiving grooves is correspondingly placed with a freeze-dried bead adapted to the detection item; the main body also includes a second receiving groove, and the second receiving groove is provided with a plurality of functional reagents that react with the freeze-dried beads; the surface of the main body is also provided with a sealing film for sealing the first receiving groove and the second receiving groove.
2. The blood coagulation multiple combined detection test strip according to claim 1, characterized in that: The freeze-dried beads are obtained by the following preparation method: Configuration: Obtain corresponding components according to the type of the test item and compound them to form liquid reagents; Making drop beads: forming the liquid reagent into droplets of expected volume, and rapidly freezing the droplets by liquid nitrogen to obtain initial frozen beads; Freeze-drying: The freeze-dried beads are collected and freeze-dried to form the freeze-dried beads with a loose network structure.
3. The coagulation multiple combined detection test strip according to claim 2, characterized in that: In the freeze-drying step, the parameters of the freeze-drying process are: Pre-freezing stage: temperature: -45℃-40℃; Duration: 3-6h; Sublimation stage: temperature: -30℃-35℃; Duration: 6-11h; vacuum degree <10pa; Analytical drying: temperature: 5℃-25℃; Duration: 4-10h; vacuum degree <10pa.
4. The coagulation multiple combined detection test strip according to claim 2, characterized in that: In the freeze-drying step, the sublimation stage is divided into: The first sublimation stage: temperature: -30℃-35℃; Duration: 4-7h; vacuum degree <10pa; Second sublimation stage: temperature: -20℃-25℃; Duration: 2-4h; vacuum degree <10pa.
5. The coagulation multiple combined detection test strip according to claim 2, characterized in that: In the freeze-drying step, the analytical drying is divided into: First analysis stage: temperature: 5℃-10℃; Duration: 2-4h; vacuum degree <10pa; Second analysis stage: temperature: 20℃-25℃; Duration: 2-6h; vacuum degree <10pa.
6. The blood coagulation multiple combined detection test strip according to claim 1, characterized in that: The types of the detection items are APTT, PT, TT and FIB.
7. The blood coagulation multiple combined detection test strip according to claim 2, characterized in that: The freeze-dried beads used for detecting the APTT project are silica freeze-dried beads, which are compounded with buffer, silica, cephalin, stabilizer, preservative and plasticizer; The freeze-dried beads used for detecting the PT project are tissue factor freeze-dried reagents, and the tissue factor freeze-dried beads are compounded with a buffer, recombinant tissue factor rhTF, a stabilizer, a preservative, and a plasticizer; The freeze-dried beads used for detecting the TT project are bovine thrombin freeze-dried reagents, which are compounded with buffer, silica, cephalin, stabilizer, preservative and plasticizer; The freeze-dried beads used for detecting the FIB project are standard bovine thrombin freeze-dried reagents, which are compounded with a buffer, bovine thrombin, a stabilizer, a preservative and a plasticizer.
8. The coagulation multiple combined detection test strip according to claim 1, characterized in that: The functional reagents are a complex solution, an APTT reagent R1 and a sample diluent.
9. The blood coagulation multiple combined detection test strip according to claim 1, characterized in that: The inner wall width of the first accommodating groove gradually increases from the groove bottom to the groove opening.
10. A detection device, characterized in that: Used to detect the coagulation multiple combined detection test strip according to any one of claims 1-9.
